In contrast, combined T/P and Taz treatment led to further increased T cell and NK cell infiltration and GZMB expression, culminating in tumor regressions in 8/17 of PDAC-bearing KPC GEMMs and significantly increased overall survival in the absence of a detectable apoptotic response (Fig. 7f–h). This evidence concerns the gene GZMB and neoplasm.